Investigators conducted a systematic review and meta-analysis to compare direct oral anticoagulants and vitamin K antagonists for the treatment of left ventricular thrombosis.
Testing for antibodies to platelet factor 4 positive in 22 of 23 patients; treatment with platelet transfusion should be avoided.
Researchers sought to assess the incidence of thrombotic complications in the second wave of patients with COVID-19, how many patients had diagnostic imaging for these complications, overall mortality, and then compared these outcomes with the first wave.
The AstraZeneca vaccine, developed with researchers from Oxford University, has been heavily used in Britain
Results of a rodent model show that fibrin-specific core-shell nanogels with a tissue-type plasminogen activator warrants more study as a treatment for patients with DIC.
Recommendations are presented for the prevention and treatment of venous thromboembolism in patients with cancer.
A novel diagnostic algorithm was able to safely rule out DVT in patients visiting an emergency department, thereby reducing the need for ultrasound imaging.
In minor procedures, coagulation differences may not be clinically significant to determine bleeding or thrombotic periprocedure complication risks.
Prothrombotic autoantibodies, similar to those with antiphospholipid syndrome, appear to be elevated in hospitalized patients with COVID-19.
New research has not found RBC transfusion to be an independent risk factor for venous or arterial thrombosis in hospitalized patients.
